3Chang S, Suvert DM, Hageman JC, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene [ J ]. N Engl J Med,2003,348 (14): 1342
4Hanaki H, Labischinski H, Inaba Y, et al. Increase in glutaminenon-amidated muropeptidas in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50[ J ]. Antimicrob Agents Chemother, 1998,42 (3): 315
5longzhu C, Xiaoxue M, Katsuhiro S, et al. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus[ J ] . Clin Microbiol ,2003 , 41 ( 1 ) :5
6Maki H, McCallum N, Bischoff M, et al. tcaA inactivation increases glycopeptide resistance in Staphylococcus aureus [ J ]. Antimicrob Agents Chemother, 2004,48 (6): 1953
7Sakoulas G, Eliopoulos GM, Moellering RC, et al. Staphylococcus aureus accessory gene regulator (agr) group Ⅱ: is there a relationship to the development of intermediate level glycopeptide resistance? [ J ]. Infect Dis,2003,187:929
8Walsh TR, Howe RA. The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus [ J ]. Annu Rev Microbiol, 2002, 56:657
9Finan JE, Archer GL, Pucci MI, et al. Role of penicillinbinding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureus[ J ]. Antimicrob Agents Chemother,2001, 45 ( 11 ):3070
10Susan B, Shaohui Y, Mamatha C, et al. Transcriptional induction of the penicillin-banding protein 2 gene in Staphylococcus aureus by cell wall-active antibiotics oxacillin and vancomycin [ J ]. Antimicrob Agents Chemother, 2003,47 ( 3 ):1028
